VYNE Therapeutics Inc. (VYNE)
NASDAQ: VYNE · Real-Time Price · USD
0.6004
+0.0067 (1.13%)
Feb 27, 2026, 4:00 PM EST - Market closed

Revenue by Segment

Millions USD. Fiscal year is Jan - Dec.
Fiscal Year
FY 2024FY 2023FY 2022FY 2021FY 2020FY 2019FY 2018FY 2017FY 2016FY 2015
Period Ending
Dec '24 Dec '23 Dec '22 Dec '21 Dec '20 Dec '19 Dec '18 Dec '17 Dec '16 Dec '15
Pharmaceuticals
501.00K424.00K477.00K931.00K20.99M
Pharmaceuticals Growth
18.16%-11.11%-48.76%-95.57%4638.83%
Total
501.00K424.00K477.00K931.00K20.99M
Total Growth
18.16%-11.11%-48.76%-95.57%4638.83%
Source: S&P Global Market Intelligence.